Logo image of ALTRI.PA

TRILOGIQ (ALTRI.PA) Stock Fundamental Analysis

EPA:ALTRI - Euronext Paris - Matif - FR0010397901 - Common Stock - Currency: EUR

5.7  0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ALTRI. ALTRI was compared to 103 industry peers in the Machinery industry. ALTRI is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ALTRI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ALTRI had positive earnings in the past year.
In the past year ALTRI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ALTRI reported negative net income in multiple years.
Of the past 5 years ALTRI 4 years had a positive operating cash flow.
ALTRI.PA Yearly Net Income VS EBIT VS OCF VS FCFALTRI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2022 2023 2024 0 5M -5M

1.2 Ratios

ALTRI has a Return On Assets (3.69%) which is in line with its industry peers.
The Return On Equity of ALTRI (4.15%) is comparable to the rest of the industry.
ALTRI's Return On Invested Capital of 2.04% is on the low side compared to the rest of the industry. ALTRI is outperformed by 73.79% of its industry peers.
Industry RankSector Rank
ROA 3.69%
ROE 4.15%
ROIC 2.04%
ROA(3y)1.1%
ROA(5y)N/A
ROE(3y)1.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALTRI.PA Yearly ROA, ROE, ROICALTRI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2022 2023 2024 0 5 -5 -10 -15 -20

1.3 Margins

ALTRI's Profit Margin of 6.44% is fine compared to the rest of the industry. ALTRI outperforms 74.76% of its industry peers.
With a Operating Margin value of 3.60%, ALTRI is not doing good in the industry: 66.02% of the companies in the same industry are doing better.
ALTRI has a Gross Margin of 61.33%. This is amongst the best in the industry. ALTRI outperforms 89.32% of its industry peers.
ALTRI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.6%
PM (TTM) 6.44%
GM 61.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y12.87%
ALTRI.PA Yearly Profit, Operating, Gross MarginsALTRI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2022 2023 2024 0 20 -20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALTRI is destroying value.
Compared to 1 year ago, ALTRI has about the same amount of shares outstanding.
Compared to 5 years ago, ALTRI has about the same amount of shares outstanding.
ALTRI has a worse debt/assets ratio than last year.
ALTRI.PA Yearly Shares OutstandingALTRI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2022 2023 2024 1M 2M 3M
ALTRI.PA Yearly Total Debt VS Total AssetsALTRI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2022 2023 2024 20M 40M 60M

2.2 Solvency

ALTRI has an Altman-Z score of 5.42. This indicates that ALTRI is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 5.42, ALTRI belongs to the best of the industry, outperforming 95.15% of the companies in the same industry.
ALTRI has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
ALTRI has a Debt to FCF ratio of 0.01. This is amongst the best in the industry. ALTRI outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that ALTRI is not too dependend on debt financing.
ALTRI has a better Debt to Equity ratio (0.00) than 98.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 5.42
ROIC/WACC0.25
WACC8.07%
ALTRI.PA Yearly LT Debt VS Equity VS FCFALTRI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2022 2023 2024 0 20M 40M

2.3 Liquidity

ALTRI has a Current Ratio of 8.37. This indicates that ALTRI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 8.37, ALTRI belongs to the top of the industry, outperforming 99.03% of the companies in the same industry.
ALTRI has a Quick Ratio of 7.34. This indicates that ALTRI is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ALTRI (7.34) is better than 99.03% of its industry peers.
Industry RankSector Rank
Current Ratio 8.37
Quick Ratio 7.34
ALTRI.PA Yearly Current Assets VS Current LiabilitesALTRI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2022 2023 2024 10M 20M 30M 40M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 351.18% over the past year.
ALTRI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.50%.
The Revenue has been decreasing by -5.51% on average over the past years.
EPS 1Y (TTM)351.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%426.85%
Revenue 1Y (TTM)8.5%
Revenue growth 3YN/A
Revenue growth 5Y-5.51%
Sales Q2Q%10.37%

3.2 Future

ALTRI is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by 0.00% yearly.
ALTRI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.04% yearly.
EPS Next Y2.86%
EPS Next 2Y0%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.96%
Revenue Next 2Y5.04%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALTRI.PA Yearly Revenue VS EstimatesALTRI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALTRI.PA Yearly EPS VS EstimatesALTRI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 -1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.26, which indicates a correct valuation of ALTRI.
68.93% of the companies in the same industry are more expensive than ALTRI, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 24.21, ALTRI is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 15.37, the valuation of ALTRI can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALTRI is on the same level as its industry peers.
ALTRI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.26
Fwd PE 15.37
ALTRI.PA Price Earnings VS Forward Price EarningsALTRI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ALTRI is valued a bit cheaper than 77.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.11
EV/EBITDA -12.36
ALTRI.PA Per share dataALTRI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALTRI does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.64
PEG (5Y)N/A
EPS Next 2Y0%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALTRI!.
Industry RankSector Rank
Dividend Yield N/A

TRILOGIQ

EPA:ALTRI (5/6/2025, 7:00:00 PM)

5.7

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-24 2024-07-24/amc
Earnings (Next)N/A N/A
Inst Owners1.72%
Inst Owner ChangeN/A
Ins Owners76.77%
Ins Owner ChangeN/A
Market Cap21.32M
Analysts86.67
Price Target6.12 (7.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 13.26
Fwd PE 15.37
P/S 0.89
P/FCF 9.11
P/OCF 7.53
P/B 0.57
P/tB 0.57
EV/EBITDA -12.36
EPS(TTM)0.43
EY7.54%
EPS(NY)0.37
Fwd EY6.51%
FCF(TTM)0.63
FCFY10.98%
OCF(TTM)0.76
OCFY13.28%
SpS6.44
BVpS9.99
TBVpS9.99
PEG (NY)4.64
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.69%
ROE 4.15%
ROCE 2.29%
ROIC 2.04%
ROICexc 5.19%
ROICexgc 5.2%
OM 3.6%
PM (TTM) 6.44%
GM 61.33%
FCFM 9.72%
ROA(3y)1.1%
ROA(5y)N/A
ROE(3y)1.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y12.87%
F-Score6
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0.01
Cap/Depr 61.5%
Cap/Sales 2.04%
Interest Coverage 250
Cash Conversion 169.89%
Profit Quality 151.07%
Current Ratio 8.37
Quick Ratio 7.34
Altman-Z 5.42
F-Score6
WACC8.07%
ROIC/WACC0.25
Cap/Depr(3y)36.94%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.62%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)351.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%426.85%
EPS Next Y2.86%
EPS Next 2Y0%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.5%
Revenue growth 3YN/A
Revenue growth 5Y-5.51%
Sales Q2Q%10.37%
Revenue Next Year4.96%
Revenue Next 2Y5.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y299.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year185.71%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y160.58%
FCF growth 3YN/A
FCF growth 5Y4.14%
OCF growth 1Y128.2%
OCF growth 3YN/A
OCF growth 5Y4.07%